Dr. Richard Wille, MD

NPI: 1689656662
Total Payments
$4,855
2024 Payments
$1,311
Companies
37
Transactions
344
Medicare Patients
4,532
Medicare Billing
$534,099

Payment Breakdown by Category

Food & Beverage$4,826 (99.4%)
Other$29.46 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,826 343 99.4%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $29.46 1 0.6%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $759.57 54 $0 (2024)
Allergan Inc. $713.98 50 $0 (2018)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $614.61 42 $0 (2024)
ABBVIE INC. $501.42 33 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $270.29 23 $0 (2024)
Gilead Sciences, Inc. $245.04 27 $0 (2018)
PFIZER INC. $191.60 12 $0 (2024)
UCB, Inc. $155.06 11 $0 (2018)
Intercept Pharmaceuticals, Inc. $138.67 8 $0 (2024)
Lilly USA, LLC $111.60 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,311 64 Janssen Biotech, Inc. ($268.78)
2023 $597.44 35 Janssen Biotech, Inc. ($135.36)
2022 $104.36 3 Boston Scientific Corporation ($98.48)
2021 $3.05 1 PFIZER INC. ($3.05)
2019 $29.66 2 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.72)
2018 $1,801 147 Allergan Inc. ($426.99)
2017 $1,008 92 Allergan Inc. ($286.99)

All Payment Transactions

344 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/16/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $19.39 General
Category: Immunology
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.40 General
Category: Gastroenterology
12/09/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $26.06 General
Category: Immunology
11/25/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.61 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/19/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $21.49 General
Category: Immunology
11/12/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $22.30 General
Category: ENDOCRINOLOGY
11/11/2024 Enterra Medical, Inc. Food and Beverage In-kind items and services $29.53 General
11/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $24.41 General
Category: IMMUNOLOGY
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.88 General
Category: Gastroenterology
10/30/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $124.74 General
Category: Immunology
10/25/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $25.37 General
Category: GASTROENTEROLOGY
10/25/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $17.29 General
Category: Gastroenterology
10/21/2024 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $16.90 General
Category: GI
10/16/2024 Sandoz Inc. Food and Beverage In-kind items and services $19.28 General
10/14/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.78 General
Category: Gastroenterology
10/03/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $13.86 General
Category: INFLAMMATION AND IMMUNOLOGY
10/02/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $12.18 General
Category: Immunology
09/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.74 General
Category: Gastroenterology
09/25/2024 Mauna Kea Technologies, Inc. Food and Beverage Cash or cash equivalent $17.31 General
09/23/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $10.68 General
Category: Immunology
09/18/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $25.63 General
Category: Immunology
09/16/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $24.19 General
Category: Hepatology / Gastroenterology
09/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.33 General
Category: Gastroenterology
09/12/2024 Mauna Kea Technologies, Inc. Food and Beverage Cash or cash equivalent $14.39 General
09/10/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $20.22 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 18 1,167 1,392 $441,856 $141,997
2022 18 1,135 1,309 $404,173 $133,525
2021 19 1,232 1,462 $442,839 $142,624
2020 17 998 1,156 $348,428 $115,953
Total Patients
4,532
Total Services
5,319
Medicare Billing
$534,099
Procedure Codes
72

All Medicare Procedures & Services

72 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 262 431 $61,202 $26,339 43.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 111 111 $54,723 $20,824 38.1%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 91 91 $44,954 $17,049 37.9%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 88 89 $58,941 $13,137 22.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 49 49 $34,823 $10,469 30.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 100 119 $23,919 $9,716 40.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 118 118 $53,336 $9,663 18.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 42 42 $20,460 $5,952 29.1%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 42 49 $21,462 $5,757 26.8%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 65 65 $21,125 $5,059 23.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 51 78 $9,048 $3,889 43.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 52 52 $9,100 $3,865 42.5%
45384 Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery Facility 2023 16 16 $10,200 $2,590 25.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 24 24 $6,288 $2,544 40.5%
43237 Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth Facility 2023 13 13 $6,708 $2,070 30.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 12 13 $2,743 $1,348 49.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 17 18 $1,998 $1,155 57.8%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 14 14 $826.00 $570.50 69.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 222 313 $44,446 $18,821 42.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 91 91 $44,900 $17,852 39.8%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 91 91 $58,149 $13,773 23.7%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 55 55 $27,170 $10,848 39.9%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 101 107 $48,364 $9,670 20.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 83 100 $20,100 $8,916 44.4%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 59 59 $26,845 $8,700 32.4%

About Dr. Richard Wille, MD

Dr. Richard Wille, MD is a Gastroenterology healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689656662.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Wille, MD has received a total of $4,855 in payments from pharmaceutical and medical device companies, with $1,311 received in 2024. These payments were reported across 344 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,826).

As a Medicare-enrolled provider, Wille has provided services to 4,532 Medicare beneficiaries, totaling 5,319 services with total Medicare billing of $534,099. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Troy, MI
  • Active Since 11/16/2005
  • Last Updated 09/17/2013
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1689656662

Products in Payments

  • LINZESS (Drug) $628.02
  • STELARA (Biological) $585.91
  • XIFAXAN (Drug) $339.69
  • VIBERZI (Drug) $209.87
  • RINVOQ (Biological) $192.71
  • TREMFYA (Drug) $173.66
  • DUPIXENT (Biological) $158.50
  • Cimzia (Drug) $155.06
  • ZENPEP (Drug) $128.42
  • Amitiza (Drug) $119.74
  • Entyvio (Biological) $115.92
  • OMVOH (Drug) $111.60
  • OCALIVA (Drug) $106.52
  • RELISTOR (Drug) $103.92
  • SpyGlass (Device) $98.48
  • ENTYVIO (Biological) $96.89
  • EUCRISA (Drug) $95.41
  • Humira (Biological) $88.28
  • APRISO (Drug) $88.13
  • XELJANZ (Drug) $74.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Troy